Cargando…
Senecavirus A 3C Protease Mediates Host Cell Apoptosis Late in Infection
Senecavirus A (SVA), an oncolytic picornavirus used for cancer treatment in humans, has recently emerged as a vesicular disease (VD)-causing agent in swine worldwide. Notably, SVA-induced VD is indistinguishable from foot-and-mouth disease (FMD) and other high-consequence VDs of pigs. Here we invest...
Autores principales: | Fernandes, Maureen H. V., Maggioli, Mayara F., Otta, Jaelin, Joshi, Lok R., Lawson, Steve, Diel, Diego G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424860/ https://www.ncbi.nlm.nih.gov/pubmed/30918505 http://dx.doi.org/10.3389/fimmu.2019.00363 |
Ejemplares similares
-
A Novel Live Attenuated Vaccine Candidate Protects Against Heterologous Senecavirus A Challenge
por: Sharma, Bishwas, et al.
Publicado: (2019) -
Prolonged Viability of Senecavirus A in Exposed House Flies (Musca domestica)
por: Turner, Justin Heath, et al.
Publicado: (2022) -
The game between host antiviral innate immunity and immune evasion strategies of senecavirus A - A cell biological perspective
por: Zhao, Kuan, et al.
Publicado: (2022) -
Senecavirus A Entry Into Host Cells Is Dependent on the Cholesterol-Mediated Endocytic Pathway
por: Jia, Meiyu, et al.
Publicado: (2022) -
Passive immunity to porcine epidemic diarrhea virus following immunization of pregnant gilts with a recombinant orf virus vector expressing the spike protein
por: Joshi, Lok R., et al.
Publicado: (2018)